Original Research Papers
1. N.G. Than, B. Sümegi, G.N. Than, Z. Berente, H. Bohn:


Our Vision
Genesis Theranostix Group aims to provide the
best-in-class first trimester screening test and prevent the development of preeclampsia.

Our Scientists
current or former section heads at NIH discovered new disease pathways of preeclampsia using advanced systems biology tools, and developed a novel platform for the early and accurate diagnosis.

Our Group
headquartered in Budapest and San Diego uses this IP to develop a first trimester screening test to enable early and personalized preventive therapies.